POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 1 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $101,993 | +35.2% | 42,854 | 0.0% | 0.01% | +28.6% |
| Q2 2023 | $75,424 | -42.9% | 42,854 | 0.0% | 0.01% | -41.7% |
| Q1 2023 | $131,991 | -41.9% | 42,854 | 0.0% | 0.01% | -47.8% |
| Q4 2022 | $227,126 | +24.1% | 42,854 | -17.4% | 0.02% | +15.0% |
| Q3 2022 | $183,000 | +18.8% | 51,854 | -13.1% | 0.02% | +25.0% |
| Q2 2022 | $154,000 | -40.1% | 59,659 | +3.8% | 0.02% | -33.3% |
| Q1 2022 | $257,000 | -46.7% | 57,469 | -13.2% | 0.02% | -51.0% |
| Q3 2021 | $482,000 | +31.0% | 66,185 | +80.1% | 0.05% | +28.9% |
| Q2 2021 | $368,000 | +4.8% | 36,754 | 0.0% | 0.04% | -5.0% |
| Q1 2021 | $351,000 | -13.8% | 36,754 | -19.8% | 0.04% | -25.9% |
| Q3 2020 | $407,000 | – | 45,833 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,043,267 | $7,605,000 | 1.52% |
| Privium Fund Management (UK) Ltd | 48,470 | $353,000 | 0.38% |
| Pentwater Capital Management LP | 4,967,227 | $36,211,000 | 0.37% |
| J. Goldman & Co LP | 301,391 | $2,197,000 | 0.11% |
| Perceptive Advisors | 787,745 | $5,743,000 | 0.08% |
| KNOTT DAVID M | 29,566 | $216,000 | 0.08% |
| Virtus ETF Advisers LLC | 23,082 | $168,000 | 0.07% |
| Altium Capital Management LP | 32,238 | $235,000 | 0.06% |
| Advisory Services Network, LLC | 268,290 | $1,956,000 | 0.06% |
| MCF Advisors LLC | 66,185 | $482,000 | 0.05% |